Propertie
Compound
Inhibition of JAKs IC
50
(nM)
Structure
Pharmacophore
JAK1
JAK2
JAK3
TYK2
Tasocitinib
3.3
2.8
19
428
pyrrolopyrimidine
Ruxolitinib
3.2
4.1
1.6
19
pyrrolopyrimidine
Baricitinib
59
57
-
-
pyrrolopyrimidine
Table 2:
Comparison of Tasocitinib, Ruxolitinib, Baricitinib.